Dysregulation of Growth Hormone Axis after Roux-en-Y Gastric Bypass

Clicks: 8
ID: 333367
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #422 of 432 articles by views in the journal of clinical endocrinology & metabolism

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Context Bariatric metabolic surgery has potent effects on glucose metabolism, with increases in insulin sensitivity and insulin secretion contributing to both improved glycemia and/or remission of type 2 diabetes (T2D) and development of hypoglycemia (post-bariatric hypoglycemia, PBH). Previous studies suggest GH secretion and/or action are altered after bariatric surgery and may mediate early post-surgical improvements in glycemic control. Given the importance of GH signaling in glucose metabolism, we hypothesized that reductions in GH signaling and/or action could also contribute to PBH. Objective Assessment of GH responses to two distinct stimuli: (1) experimental hypoglycemia induced by hyperinsulinemic hypoglycemic clamp and (2) glucagon stimulation. Setting Academic medical center PARTICIPANTS Individuals with history of Roux-en-Y gastric bypass (RYGB) with PBH (n=20), without hypoglycemia (n=20), and weight-matched non-surgical controls (n=10). Main outcomes GH responses were assessed (1) during experimental hypoglycemia and (2) after glucagon stimulation. Plasma GH receptor (GHR) and insulin-like growth factors and binding proteins were also measured. Results Glucagon-stimulated GH levels were 5–6 times higher in both post-RYGB groups vs. controls at 120 minutes: control: 481±137 pg/ml; RYGB non-hypo 2521 ± 678 pg/ml; PBH: 3018 ±137pg/ml (control vs RYGB non-hypo p=0.02; control vs PBH; p=0.005). In contrast, PBH participants showed lower GH responses to experimental hypoglycemia. Additionally, plasma GHR and IGF-1 levels were reduced in PBH vs. controls. Conclusions We find that plasma GH response to 2 distinct experimental stimuli differed in participants with a history of bariatric surgery. However, these patterns did not differ in those with and without PBH. Further studies will be required to determine if tissue-level alterations in GH action contribute to improved glycemic control after bariatric surgery.
Reference Key
openalex_W7223124897 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lei Pei, CAMERON J. CUMMINGS, Hamayle Saeed, Alessandra Amore, Maryam Farahmandsadr, Amanda Lyn Sheehan, Rafael Ferraz Bannitz, Donald C. Simonson, Mary‐Elizabeth Patti
Journal the journal of clinical endocrinology & metabolism
Year 2026
DOI
10.1210/clinem/dgag428
URL
https://doi.org/10.1210/clinem/dgag428
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.